Marco Valgimigli

Showing 1-20 of 56 articles

Coronary interventions

Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions

Zimarino M, Angiolillo D, Dangas G, Capodanno D, Barbato E, Hahn J, Giustino G, Watanabe H, Costa F, Cuisset T, Rossini R, Sibbing D, Burzotta F, Louvard Y, Shehab A, Renda G, Kimura T, Gwon H, Chen S, Costa R, Koo B, Storey R, Valgimigli M, Mehran R, Stankovic G

September 15, 2020 | 10.4244/EIJ-D-20-00885

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

August 28, 2020 | 10.4244/EIJ-D-20-00052

Coronary interventions

Cardiovascular mortality and morbidity in patients undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a systematic review and meta-analysis

Spirito A, Gargiulo G, Siontis G, Mitsis A, Billinger M, Windecker S, Valgimigli M

July 7, 2020 | 10.4244/EIJ-D-20-00221

Coronary interventions

Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys P, Hamm C, Steg P, Heg D, Branca M, Jüni P, Windecker S, Valgimigli M, Benit E, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Liebetrau C

June 2, 2020 | 10.4244/EIJ-D-20-00145

The SYNTAX score on its way out or … towards artificial intelligence: part I

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y

May 20, 2020 | 10.4244/EIJ-D-19-00543A

The SYNTAX score on its way out or … towards artificial intelligence: part II

May 20, 2020 | 10.4244/EIJ-D-19-00543B

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabate M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg P, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

April 3, 2020 | 10.4244/EIJ-D-19-00699

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Coronary interventions

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabate M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Transradial left main PCI is safe and effective

Jolly S, Valgimigli M

November 20, 2018 | 10.4244/EIJV14I10A192

A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial

Iglesias JF, Mueller O, Zaugg S, Roffi M, Kurz D, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, Jüni P, Windecker S, Pilgrim T

August 24, 2018 | 10.4244/EIJ-D-17-00734

Current use of intracoronary imaging in interventional practice – Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey

Koskinas K, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne R

July 20, 2018 | 10.4244/EIJY18M03_01

STEMI

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabate M

March 20, 2018 | 10.4244/EIJ-D-17-00608

Coronary interventions

State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation – past, present and future perspectives

Gargiulo G, Valgimigli M, Capodanno D, Bittl J

August 25, 2017 | 10.4244/EIJ-D-17-00468

Coronary interventions

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabate M

August 4, 2017 | 10.4244/EIJ-D-16-00512

Coronary interventions

Will PIONEER AF-PCI change my practice?

Ukena C, Leonardi S, Palmerini T, Lansky A, Montalescot G, Valgimigli M

August 4, 2017 | 10.4244/EIJV13I5A95

Coronary interventions

Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial

Piccolo R, Magnani G, Ariotti S, Gargiulo G, Marino M, Santucci A, Franzone A, Tebaldi M, Heg D, Windecker S, Valgimigli M

May 15, 2017 | 10.4244/EIJ-D-16-00497

Interventions for valvular disease

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T

April 7, 2017 | 10.4244/EIJ-D-16-00790

Coronary interventions

A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis

Colombo A, Basavarajaiah S, Limbruno U, Picci A, Lettieri C, Valgimigli M, Sciahbasi A, Prati F, Calabresi M, Pierucci D, Guglielmotti A

December 9, 2016

Latest news

NEW ISSUE

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Hinge point-based aortic annular plane

September 18, 2020

NEW

Ahead of print: Histopathology of embolic debris during TAVI

September 18, 2020

Editorial

Transcatheter VIV implantation for failed surgical bioprostheses

J. Mehilli

September 18, 2020

PCR Trials

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Twitter

Over 10,000 followers

Thank you!

September 18, 2020

Editorial

Steady-state hyperaemia: many routes, one goal

G.G. Toth

September 18, 2020

JAA

This Week's JAA's: Leaflex study, Coronary access after REDO-TAVI...